Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02PQB
|
|||
| Former ID |
DIB008107
|
|||
| Drug Name |
ATX-101
|
|||
| Synonyms |
ATX-101, APIM Therapeutics; Proliferating cell nuclear antigen (peptide, cancer), APIM
Click to Show/Hide
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66] | Phase 3 | [1], [2] | |
| Company |
Bayer HealthCare Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H40O4
|
|||
| Canonical SMILES |
CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C
|
|||
| InChI |
1S/C24H40O4/c1-14(4-9-22(27)28)18-7-8-19-17-6-5-15-12-16(25)10-11-23(15,2)20(17)13-21(26)24(18,19)3/h14-21,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15-,16-,17+,18-,19+,20+,21+,23+,24-/m1/s1
|
|||
| InChIKey |
KXGVEGMKQFWNSR-LLQZFEROSA-N
|
|||
| CAS Number |
CAS 83-44-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
7102, 74413, 585592, 585594, 618558, 819839, 828927, 837869, 841387, 855438, 3135058, 7850928, 7887027, 7887240, 8138505, 9377073, 11446298, 14717701, 15953970, 24277530, 24858743, 24893692, 24893857, 25622261, 29204024, 30425733, 46391767, 47193711, 47959957, 50086825, 53777021, 53786947, 56311772, 57399984, 80526818, 85279390, 90451786, 93167216, 99444161, 99455580, 103578732, 113476161, 124807327, 124812927, 125011664, 125308743, 126523430, 126596873, 126606721, 127310875
|
|||
| ChEBI ID |
CHEBI:28834
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 610). | |||
| REF 2 | Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells. PLoS One. 2013 Jul 31;8(7):e70430. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.